KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Total Liabilities (2016 - 2026)

Emergent BioSolutions has reported Total Liabilities over the past 17 years, most recently at $797.3 million for Q1 2026.

  • For Q1 2026, Total Liabilities fell 8.71% year-over-year to $797.3 million; the TTM value through Mar 2026 reached $797.3 million, down 8.71%, while the annual FY2025 figure was $796.0 million, 12.23% down from the prior year.
  • Total Liabilities for Q1 2026 was $797.3 million at Emergent BioSolutions, roughly flat from $796.0 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $1.8 billion in Q4 2022 and troughed at $796.0 million in Q4 2025.
  • A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: surged 44.98% in 2023 and later tumbled 34.77% in 2024.
  • Year by year, Total Liabilities stood at $1.8 billion in 2022, then tumbled by 34.0% to $1.2 billion in 2023, then fell by 22.74% to $906.9 million in 2024, then decreased by 12.23% to $796.0 million in 2025, then grew by 0.16% to $797.3 million in 2026.
  • Business Quant data shows Total Liabilities for EBS at $797.3 million in Q1 2026, $796.0 million in Q4 2025, and $878.5 million in Q3 2025.